Activity Title: 2018 Virtual Symposium: Advances in HFpEF: Addressing Diagnostic and Treatment Challenges
Activity Format: Virtual Symposium
Program Description:
Prognosis and treatment of HF patients with preserved ejection fraction (HFpEF) is complicated by diagnostic challenges and complicated pathophysiologies. Compared to HF patients with reduced ejection fraction (HFrEF), HFpEF patients are generally older, more often female, and have increased metabolic comorbidities such as obesity, hypertension, and type 2 diabetes mellitus. These metabolic comorbidities are associated with an increased risk of developing HFpEF, making the increase in metabolic syndrome in the recent decades particularly concerning. The lack of specific therapies for HFpEF have contributed to the increased prevalence and prognosis of the disease, and along with complicated diagnosis and pathophysiologies, contribute to the challenges that clinicians face in managing HFpEF.
To address these clinical practice gaps, expert faculty will focus on the latest evidence-based strategies to manage HFpEF. This 2018 virtual symposium activity will also provide an overview on current and emerging resources and procedures designed to lower hospital readmission rates in HFpEF patients.
Estimated Time to Complete: 1.0 hours
Release Date: December 21, 2018
Expiration Date: December 21, 2019
Credit Type(s) Available: ACCME, CDR, ACPE, ANCC
Maximum Credits: 1.0 hour
Provided By: This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.
Commercial Supporter:
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Intended Audience:
US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Employ current and emerging approaches and tools to diagnose HFpEF
- Identify current treatment guideline recommendations for HFpEF
- Recognize current gaps in the guidelines for the treatment of HFpEF
- Interpret results from clinical trials for emerging evidence-based therapies for patients with HFpEF
- Outline practices and resources aimed to improve hospital readmission rates for patients with HFpEF
Faculty Information:
JoAnn Lindenfeld, MD (Chair)
- Director, Heart Failure and Transplant
- Professor of Medicine
- Vanderbilt University School of Medicine
- Nashville, TN
Consultant/Independent Contractor: Abbott, VWare, Relypsa, Novartis, Edwards
Grant/Research Support: AstraZeneca
Keith C. Ferdinand, MD, FACC, FAHA
- Professor of Medicine
- Tulane University School of Medicine
- Tulane Heart and Vascular Institute
- New Orleans, LA
Consultant/Independent Contractor: Amgen, Sanofi, Novartis, Quantum Genomics, Boehringer Ingelheim
Alanna A. Morris, MD
- Assistant Professor of Medicine, Division of Cardiology
- Emory University Clinical Cardiovascular Research Institute
- Atlanta, GA
Dr. Morris has nothing to disclose.
Disclosure of Conflicts of Interest:
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Accreditor Disclosures:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ashley Marostica, RN, MSN; Lindsay Borvansky; Andrea Funk; Amanda Turner; Erin Franceschini, MS; Karin McAdams all have nothing to disclose.
Accreditation:
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement(s):
Physician Credit Designation
Global Education Group designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
There are 0.3 pharmacotherapy hours available for this activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Universal Activity Number (UAN): 0530-9999-18-427-H01-P
Dietician Accreditation Statement
Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activities / materials.
CPE Provider #GE012
Global Contact Information:
For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions for CME/CE Credit:
This activity is offered at no cost to participants. During the period December 21, 2018 through December 21, 2019, participants must follow these steps in order to receive CME/CE credit:
- Sign In or Register at https://www.cardiometabolichealth.org/my-account.html
- Read and accept the Terms & Conditions including the learning objectives and faculty disclosures.
- Complete the pre-test by recording the best answer to each question in the answer key. There is no scoring of the pre-test questions section.
- Review the educational activity.
- Complete the post-test by recording the best answer to each question in the answer key. Successful completion of the post-test is required to earn CME/CE credit. Successful completion is defined as a cumulative score of at least 70%.
- Complete the online evaluation form.
- After successfully completing the post-test and online evaluation form, your CME/CE certificate will be generated and will be available immediately for print.
Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6-10 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed.
For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Hardware and Software Requirements:
This online activity must be viewed with the latest version of Chrome, Firefox or Internet Explorer. If you do not have these browsers, you can download Chrome here, Firefox here and Internet Explorer here. Optimal viewing requires a broadband connection of at least 3 Mbps and a 1 GHz processor with 1 GB RAM.
